InnoMedCatalyst launches a new opportunity for healthcare providers to step beyond traditional roles and become real-world test beds and co-creators of innovation in 5P Medicine.
Hospitals, clinical centres, laboratories and care organisations are invited to:
- Identify and submit unmet clinical or operational needs
- Collaborate with innovative MedTech and HealthTech providers
- Co-develop and validate solutions in real healthcare environments
Focus areas:
AI & digital health, genomics, clinical decision support, personalised therapies, data integration & interoperability — all aligned with the 5P Medicine approach.
Up to 15 healthcare providers will be selected to be matched with high-potential innovators and supported throughout the process.
Selected organisations will:
- Receive tailored matchmaking with solution providers
- Receive up to 20 hours of dedicated mentoring and coaching
- Be supported in building a strong proposal for I3 and Horizon Europe funding
- Have increased chances of securing EU funding
- Position the organisation at the forefront of healthcare innovation
Application deadline: 15 May 2026
Apply now via the LifeScience Open Space platform – Click Here!
The InnoMedCatalyst project is a European initiative aiming to enhance the regional innovation capacity of the precision and personalized medicine ecosystems across Europe, where startups, spinoffs, scaleups, innovators and healthcare providers will increase their capabilities to develop, test and refine digital health solutions as business cases, while concurrently preparing a series of interregional investment projects ready for further investment and exploitation by 2026.
